Abstract: Abstract Hyperhomocysteinemia is a risk factor for neurodegeneration, and binding of copper by homocysteine is a putative underlying mechanism. As mutations of the copper-dependent superoxide dismutase are observed in familial ALS, we tested whether genetic variants with influence on homocysteine metabolism are associated with ALS. We compared the frequency of seven variants of genes involved in homocysteine metabolism in 162 patients with sporadic ALS and 162 controls who did not significantly differ in age (t = 1.27, p = 0.205) and gender ((2) = 2.48, p = 0.115) using binary regression analysis. Results showed that the variant MTHFR c.677C>T was significantly associated with ALS, i.e. the T-allele was more frequent among patients. Explorative regression analysis revealed that MTHFR c. 
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Subjects and Methods
Serial Caucasian adult patients with sporadic ALS were recruited at the Departments of Neurology of the University Hospitals of Ulm, Germany, and Zurich, Switzerland. Patients were diagnosed to have definite or probable sporadic ALS by modified Airlie House El Escorial criteria (8) . In brief, diagnosis was based on clinical examination, electromyography and nerve conduction studies. Cranial and cervical magnetic resonance imaging were performed when considered necessary. Electromyography (EMG) showed signs of anterior horn cell degeneration whereas nerve conduction studies were without signs of other underlying neurological disorders. All patients underwent routine biochemical tests including thyroid hormones, serum protein electrophoresis, complete blood count and standard CSF analysis. Healthy age-and gender-matched Caucasian subjects, e.g., partner of patients without any history of neurological disease, served as controls. DNA sampling and genetic analyses were approved by the local Ethics Committees. Written informed consent for genetic analysis was obtained from each individual.
In total, 162 patients and 162 controls were enrolled (table 1). Patients and controls did not significantly differ in age (t = 1.27; p = 0.205) or gender (Chi = 2.48; p=0.115).
Genomic DNA was prepared from peripheral leukocytes and was used for genotyping of seven variants of genes involved in homocysteine metabolism by allele specific PCR amplification or by PCR amplification with subsequent restriction analysis (9) analyse independent associations between genetic variants and clinical parameters and to avoid artifacts due to multiple testing or due to any heterogeneity concerning age and gender between patients and controls, we used multivariate analyses, i.e., binary regression with all genotypes, age and gender as covariables and diagnosis "ALS" versus "control" as dependent variable to analyse associations of genotypes with the incidence of ALS as primary parameter of interest. Exploratively, the genotypes together with age and gender as covariables were analysed with age of onset or, alternatively, disease duration as dependent variable in linear regression analysis. In addition, binominal regression analysis with all genotypes, age and gender as covariables was used to analyse the association of genotypes with subtypes of the clinical presentation defined by bulbar versus spinal disease onset.
Finally, explorative analyses investigated subgroups defined by age and gender.
Results
The results of the multivariate binominal regression analysis of the genetic variants with age and gender as covariables are shown in table 2.
The variant MTHFR c.677C>T was significantly associated with ALS, i.e., the T-allele was more frequent in patients than in controls with 6% carriers of the T-allele in homozygous 
Discussion
In our study sample, the MTHFR variant c.677C>T was associated with sporadic ALS and thus may be a risk factor for the development of this disease. If subgroups were analyzed, this association was only significant for bulbar onset ALS, but not for spinal ALS. The thermolabile MTHFR variant, caused by the T-allele of MTHFR c.677C>T, reduces MTHFR activity yielding elevated homocysteine plasma levels (10) . Elevated homocysteine plasma levels are a risk factor for neurodegeneration. Binding of copper by homocysteine and an impairment of copper-dependent enzymes like cytochrome C oxidase and superoxide dismutase 1 (SOD1), which play a role in familial ALS, may be underlying mechanisms (6) .
Thus, on a genetic basis, homocysteine metabolism, speculatively via its influence on copper homeostasis, may contribute to ALS pathogenesis. However, we cannot estimate to what extent our data depend on our study population. Due to the limitations of any association study, these results must be re-tested in independent study samples, especially since the frequency of the TT genotype of MTHFR c.677C>T in the control group was lower than expected (11-13). Also, the association of MTHFR c.677C>T with bulbar ALS only, which was observed in secondary explorative subgroup analyses, and the association of DHFR c.594+59del19bp with bulbar ALS should be re-tested. The lack of association of the genetic variants with the clinical course argues against a major influence of homocysteine metabolism on ALS outcome. However, in the absence of a curative therapy approach yet, a confirmed association of elevated homocysteine plasma levels with ALS development may lead to novel prophylactic or therapeutic strategies, as reduction of homocysteine plasma levels can be easily accomplished (7).
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